LINC01140
gene geneOn this page
Also known as FLJ41676
Summary
LINC01140 (long intergenic non-protein coding RNA 1140, HGNC:27922) is a long non-coding RNA gene on chromosome 1p22.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27922 |
| Approved symbol | LINC01140 |
| Name | long intergenic non-protein coding RNA 1140 |
| Location | 1p22.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | FLJ41676 |
| Ensembl gene | ENSG00000267272 |
| Ensembl biotype | lncRNA |
| Entrez | 339524 |
| RNAcentral | URS000075CD48 — lncRNA, 3429 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 lncRNA
ENST00000461990, ENST00000467438, ENST00000469312, ENST00000471417, ENST00000476432, ENST00000484933, ENST00000490006, ENST00000587165, ENST00000589455, ENST00000590653, ENST00000619924
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000461990 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001817369 | 87133614 | 87136669 |
| ENSE00001822814 | 87129870 | 87129994 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 86.42.
FANTOM5 (CAGE): breadth broad, TPM avg 1.5437 / max 115.8156, expressed in 275 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 3891 | 0.7972 | 210 |
| 3892 | 0.1996 | 93 |
| 3890 | 0.1987 | 77 |
| 3893 | 0.1415 | 60 |
| 3894 | 0.0950 | 42 |
| 3887 | 0.0521 | 24 |
| 3888 | 0.0327 | 16 |
| 3889 | 0.0270 | 13 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right atrium auricular region | UBERON:0006631 | 86.42 | gold quality |
| pancreatic ductal cell | CL:0002079 | 84.74 | gold quality |
| omental fat pad | UBERON:0010414 | 84.71 | gold quality |
| peritoneum | UBERON:0002358 | 84.59 | gold quality |
| cardiac atrium | UBERON:0002081 | 83.93 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 83.28 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 83.04 | gold quality |
| calcaneal tendon | UBERON:0003701 | 82.26 | gold quality |
| tibial nerve | UBERON:0001323 | 82.21 | gold quality |
| apex of heart | UBERON:0002098 | 82.20 | gold quality |
| left ovary | UBERON:0002119 | 80.65 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 80.50 | gold quality |
| left coronary artery | UBERON:0001626 | 80.14 | gold quality |
| tibialis anterior | UBERON:0001385 | 79.75 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 79.62 | gold quality |
| gall bladder | UBERON:0002110 | 79.49 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 79.42 | gold quality |
| right ovary | UBERON:0002118 | 79.30 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 78.84 | gold quality |
| coronary artery | UBERON:0001621 | 77.99 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.97 | gold quality |
| heart | UBERON:0000948 | 77.85 | gold quality |
| adipose tissue | UBERON:0001013 | 77.59 | gold quality |
| thyroid gland | UBERON:0002046 | 77.25 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 76.96 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 76.91 | gold quality |
| heart left ventricle | UBERON:0002084 | 76.72 | gold quality |
| right coronary artery | UBERON:0001625 | 76.53 | gold quality |
| right lung | UBERON:0002167 | 76.50 | gold quality |
| cardiac ventricle | UBERON:0002082 | 75.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.04 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization. (PMID:33234721)
- High Levels of LINC01140 Expression Predict a Good Prognosis and Improve Radiotherapy in Sarcoma Patients. (PMID:34587432)
- LINC01140 inhibits nonsmall cell lung cancer progression and cisplatin resistance through the miR-4742-5p/TACC1 axis. (PMID:35307914)
- LINC01140 Regulates Radiosensitivity of Nasopharyngeal Carcinoma Cells Through the ceRNA Network. (PMID:35988287)
- LINC01140 Targeting miR-452-5p/RGS2 Pathway to Attenuate Breast Cancer Tumorigenesis. (PMID:36299824)
- Exosome-Mediated lncRNA LINC01140 Attenuates Breast Cancer Progression by Regulating the Wnt/beta-Catenin Pathway. (PMID:37602451)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.